Modelos “in silico” para la predicción de la absorción de fármacos administrados por vía oral (SIMCYP®): estatinas
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Citas
Drugbank 4.5. [en línea]. Alberta, Canadá: Universidad de Alberta, 2006 [Fecha de acceso: 03/06/2016] Disponible en: http://www.drugbank.ca/.
Fujikawa M, Ano R, Nakao K, Shimizu R, Akamatsu M. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorganic & Medicinal Chemistry. 2005; 13(15):4721-4732. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15936203
Giacomini KM, Huang SM, Tweedie DJ, Benet LT, Brouwer K, Chu X et al. Membrane transporters in drug development. Nature Reviews Drug Discovery. 2010; 9: 215-236. Disponible en: http://www.nature.com/nrd/journal/v9/n3/fig_tab/nrd3028_F1.html
Horio M, Chin KV, Currier SJ, Goldenberg S, Williams C, Pastan I et al. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby Canine Kidney cell epithelia. Journal of Biological Chemistry. 1989; 264(25):14880-14484. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/2570070
Hwang KK, Martin NE, Jiang L, Zhu C. Permeation prediction of M100240 using the parallel artificial membrane permeability assay. Journal of Pharmacy & Pharmaceutical Sciences. 2003; 6(3):315-320. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/14738711
Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW et al. MDCK (Madin Darby Canine Kidney) Cells: A tool for membrane permeability screening. Journal of Pharmaceutical Sciences. 1999; 88(1):28-33. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9874698
Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan et al. Population-Based Mechanistic Prediction of Oral Drug Absorption. The AAPS Journal. 2009; 11 (2):225-237. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691459/
Kansy M, Senner F, Gubernator K. Physicochemical High Throughput Screening: Parallel Artificial membrane Permeation Assay in the Description of Passive Permeation Process. Journal of Medicinal Chemistry. 1998; 41(7):1007-1010. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9544199
Kato. Intestinal first-pass metabolism of CYP3A4 substrates. Drug Metabolism and Pharmacokinetics. 2008; 23(2):87-94. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18445987
Lennernäs H. Intestinal permeability and its relevance for absorption and elimination. Xenobiotica. 2007; 37(10-11):1015-1051. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17968735
Maliepaard M, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001; 61(8): p. 3458-64. Disponible en: http://cancerres.aacrjournals.org/content/61/8/3458.long
Ranaldi G, Islam K, Sambuy Y. Epithelial Cells in Culture as a Model for the Intestinal Transport of Antimicrobial Agents. Antimicrobial Agents & Chemotherapy. 1992; 36(7):1374-1381. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC191589/
SimCyp Simulator (v. 16) [software]. 2011-2016. Princeton: Certara USA, Inc. Obtenido de: https://support.certara.com
Wang I, Hopper I. Celiac disease and drug absorption: Implications fo cardiovascular therapeutics. Cardiovascular Therapeutics. 2014; 32 253–256. Sede web: http://onlinelibrary.wiley.com/doi/10.1111/1755-5922.12094/epdf
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D668-72. 16381955